3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Risk factors for non-diabetic renal disease in diabetic patients

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 11 , 12 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 18 , 19 , 18 , 19 , 20 , 3 , 4 , 4 , 6 , 6 , 9 , 10 , 12 , 2 , 14 , 1 , 3 , 21 , 1 , 17
      Clinical Kidney Journal
      Oxford University Press
      chronic kidney disease, diabetes mellitus, diabetic nephropathy, non-diabetic renal disease, renal biopsy

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Diabetic patients with kidney disease have a high prevalence of non-diabetic renal disease (NDRD). Renal and patient survival regarding the diagnosis of diabetic nephropathy (DN) or NDRD have not been widely studied. The aim of our study is to evaluate the prevalence of NDRD in patients with diabetes and to determine the capacity of clinical and analytical data in the prediction of NDRD. In addition, we will study renal and patient prognosis according to the renal biopsy findings in patients with diabetes.

          Methods

          Retrospective multicentre observational study of renal biopsies performed in patients with diabetes from 2002 to 2014.

          Results

          In total, 832 patients were included: 621 men (74.6%), mean age of 61.7 ± 12.8 years, creatinine was 2.8 ± 2.2 mg/dL and proteinuria 2.7 (interquartile range: 1.2–5.4) g/24 h. About 39.5% ( n = 329) of patients had DN, 49.6% ( n = 413) NDRD and 10.8% ( n = 90) mixed forms. The most frequent NDRD was nephroangiosclerosis (NAS) ( n = 87, 9.3%). In the multivariate logistic regression analysis, older age [odds ratio (OR) = 1.03, 95% CI: 1.02–1.05, P < 0.001], microhaematuria (OR = 1.51, 95% CI: 1.03–2.21, P = 0.033) and absence of diabetic retinopathy (DR) (OR = 0.28, 95% CI: 0.19–0.42, P < 0.001) were independently associated with NDRD. Kaplan–Meier analysis showed that patients with DN or mixed forms presented worse renal prognosis than NDRD (P < 0.001) and higher mortality (P = 0.029). In multivariate Cox analyses, older age (P < 0.001), higher serum creatinine (P < 0.001), higher proteinuria (P < 0.001), DR (P = 0.007) and DN (P < 0.001) were independent risk factors for renal replacement therapy. In addition, older age (P < 0.001), peripheral vascular disease (P = 0.002), higher creatinine (P = 0.01) and DN (P = 0.015) were independent risk factors for mortality.

          Conclusions

          The most frequent cause of NDRD is NAS. Elderly patients with microhaematuria and the absence of DR are the ones at risk for NDRD. Patients with DN presented worse renal prognosis and higher mortality than those with NDRD. These results suggest that in some patients with diabetes, kidney biopsy may be useful for an accurate renal diagnosis and subsequently treatment and prognosis.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: not found
          • Article: not found

          CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018

            (2017)
            The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Progression of nephropathy in type 2 diabetic patients.

              Nephropathy in type 2 diabetes is the single most common cause of end-stage renal disease (ESRD), but the decline in kidney function varies considerably between individuals, and determinants of renal function loss, early in the course of renal disease, have not been clearly identified. In a prospective observational study, we followed 227 (60 female) Caucasian type 2 diabetic patients with nephropathy for 6.5 (range 3 to 17) years from a baseline glomerular filtration rate (GFR) of 83 (SD30) mL/min/1.73m(2) with 7 (range 3 to 22) measurements of GFR ((51)Cr-EDTA) per patient. We evaluated determinants of (1) rate of decline in GFR, (2) risk of doubling in serum creatinine or ESRD, and (3) mortality using potential risk factors at baseline and during follow-up. The mean (SD) rate of decline in GFR was 5.2 (4.1) mL/min/year. In multivariate regression analysis, higher baseline albuminuria, systolic blood pressure (SBP), hemoglobin A1c, GFR, age, and degree of diabetic retinopathy were significantly associated with increased rate of decline in GFR (R(2) (adj) 0.24). During follow-up, elevated mean albuminuria, SBP, hemoglobin A1c, and lower hemoglobin, heavy smoking, and presence of diabetic retinopathy were significantly associated with increased decline in GFR (R(2) (adj) 0.26). During follow-up, 63 patients had a doubling in serum creatinine or developed ESRD, and 79 patients died, primarily due to cardiovascular disease. In Cox regression analysis, higher baseline albuminuria, hemoglobin A1c, and SBP, together with lower GFR and hemoglobin, were significantly associated with shorter time to doubling of serum creatinine or ESRD. Higher baseline albuminuria, hemoglobin A1c, SBP, and age were significantly associated with increased mortality. Our long-term prospective study of type 2 diabetic patients with nephropathy has revealed several modifiable risk factors of enhanced progression in kidney disease and increased mortality.
                Bookmark

                Author and article information

                Journal
                Clin Kidney J
                Clin Kidney J
                ckj
                Clinical Kidney Journal
                Oxford University Press
                2048-8505
                2048-8513
                June 2020
                03 January 2020
                03 January 2020
                : 13
                : 3
                : 380-388
                Affiliations
                [1 ] Nephrology Department, Hospital del Mar , Barcelona, Spain
                [2 ] Nephrology Department, Fundació Althaia , Manresa, Spain
                [3 ] Nephrology Department, Hospital 12 de Octubre , Madrid, Spain
                [4 ] Nephrology Department, Hospital Universitario Fundación Alcorcón , Madrid, Spain
                [5 ] Nephrology Department, Hospital Sant Joan Despí Moisès Broggi , Barcelona, Spain
                [6 ] Nephrology Department, Clínica Universitaria de Navarra , Pamplona, Spain
                [7 ] Nephrology Department, Hospital de Poniente , Almería, Spain
                [8 ] Nephrology Department, Hospital de Palamós , Girona, Spain
                [9 ] Nephrology Department, Hospital Universitario Gregorio Marañón , Madrid, Spain
                [10 ] Nephrology Department, Fundació Puigvert , Barcelona, Spain
                [11 ] Nephrology Department, Hospital Universitari Josep Trueta , Girona, Spain
                [12 ] Nephrology Department, Hospital Germans Trias i Pujol , Badalona, Spain
                [13 ] Nephrology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria , Las Palmas, Spain
                [14 ] Nephrology Department, Hospital Universitario Ramón y Cajal , Madrid, Spain
                [15 ] Nephrology Department, Hospital San Pedro , Logroño, Spain
                [16 ] Nephrology Department, Hospital Infanta Cristina , Badajoz, Spain
                [17 ] Nephrology Department, Hospital Vall d’Hebron , Barcelona, Spain
                [18 ] Nephrology Department, Hospital Clínic , Barcelona, Spain
                [19 ] IDIBAPS, Universitat de Barcelona , Barcelona, Spain
                [20 ] Nephrology Department, Fundación Jiménez Díaz , Madrid, Spain
                [21 ] Nephrology Department, Hospital de Bellvitge, Hospitalet de Llobregat , Barcelona, Spain; Spanish Group for the Study of Glomerular Diseases (GLOSEN), Grup de Treball de Malalties Glomerulars de la Societat Catalana de. Nefrologia (GlomCAT), and Grupo Español de Estudio de Nefropatía Diabética (GEENDIAB)
                Author notes
                Correspondence to: María José Soler; E-mail: mjsoler01@ 123456gmail.com ; Twitter handle: @ PepaSolerR
                Author information
                http://orcid.org/0000-0003-3621-0766
                Article
                sfz177
                10.1093/ckj/sfz177
                7367112
                32699618
                ebf885d5-cdbf-4ff9-9196-a21961af533b
                © The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 24 August 2019
                : 15 November 2019
                Page count
                Pages: 9
                Funding
                Funded by: FONDO DE INVESTIGACIÓN SANITARIA-FEDER, ISCIII;
                Award ID: PI17/00257
                Funded by: REDINREN;
                Award ID: RD16/0009
                Categories
                Original Articles

                Nephrology
                chronic kidney disease,diabetes mellitus,diabetic nephropathy,non-diabetic renal disease,renal biopsy

                Comments

                Comment on this article